William Blair & Company’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.17M | Sell |
49,482
-3,047
| -6% | -$318K | 0.01% | 486 |
|
|
2025
Q1 | $6.13M | Sell |
52,529
-1,853
| -3% | -$216K | 0.02% | 430 |
|
|
2024
Q4 | $4.6M | Sell |
54,382
-788
| -1% | -$66.7K | 0.01% | 516 |
|
|
2024
Q3 | $4.96M | Sell |
55,170
-3,981
| -7% | -$358K | 0.01% | 506 |
|
|
2024
Q2 | $4.76M | Sell |
59,151
-4,396
| -7% | -$354K | 0.01% | 502 |
|
|
2024
Q1 | $5.07M | Buy |
63,547
+55,027
| +646% | +$4.39M | 0.02% | 477 |
|
|
2023
Q4 | $678K | Sell |
8,520
-3,750
| -31% | -$298K | ﹤0.01% | 984 |
|
|
2023
Q3 | $858K | Buy |
12,270
+400
| +3% | +$28K | ﹤0.01% | 887 |
|
|
2023
Q2 | $853K | Sell |
11,870
-1,655
| -12% | -$119K | ﹤0.01% | 896 |
|
|
2023
Q1 | $834K | Buy |
13,525
+4,175
| +45% | +$258K | ﹤0.01% | 884 |
|
|
2022
Q4 | $721K | Sell |
9,350
-1,440
| -13% | -$111K | ﹤0.01% | 931 |
|
|
2022
Q3 | $481K | Sell |
10,790
-6,100
| -36% | -$272K | ﹤0.01% | 1051 |
|
|
2022
Q2 | $647K | Buy |
16,890
+1,703
| +11% | +$65.2K | ﹤0.01% | 984 |
|
|
2022
Q1 | $629K | Sell |
15,187
-900
| -6% | -$37.3K | ﹤0.01% | 1076 |
|
|
2021
Q4 | $608K | Sell |
16,087
-2,490
| -13% | -$94.1K | ﹤0.01% | 1141 |
|
|
2021
Q3 | $612K | Buy |
18,577
+10,050
| +118% | +$331K | ﹤0.01% | 1090 |
|
|
2021
Q2 | $575K | Sell |
8,527
-80
| -0.9% | -$5.4K | ﹤0.01% | 1107 |
|
|
2021
Q1 | $487K | Sell |
8,607
-7,660
| -47% | -$433K | ﹤0.01% | 1130 |
|
|
2020
Q4 | $1.33M | Buy |
16,267
+2,075
| +15% | +$169K | ﹤0.01% | 769 |
|
|
2020
Q3 | $1.01M | Buy |
14,192
+120
| +0.9% | +$8.55K | ﹤0.01% | 756 |
|
|
2020
Q2 | $1.16M | Buy |
14,072
+7,632
| +119% | +$628K | 0.01% | 689 |
|
|
2020
Q1 | $379K | Sell |
6,440
-11,292
| -64% | -$665K | ﹤0.01% | 951 |
|
|
2019
Q4 | $1.83M | Buy |
+17,732
| New | +$1.83M | 0.01% | 622 |
|